PDI (PDII +1.3%) says one of its clients has received FDA approval to market its product. PDII...

|By:, SA News Editor

PDI (PDII +1.3%) says one of its clients has received FDA approval to market its product. PDII will provide an array of promotional services for its rollout, including a dedicated sales team, plus teledetailing and digital communications services. The contract is expected to generate total revenue of approximately $57M over the life of the two-year agreement, with $10M-$11M to be recorded over the second half of 2012.